
Alicia L. Otton
Examiner (ID: 9618)
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1626, 1699, 4121 |
| Total Applications | 1585 |
| Issued Applications | 975 |
| Pending Applications | 99 |
| Abandoned Applications | 544 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11821830
[patent_doc_number] => 20170210767
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-27
[patent_title] => 'LYSOPHOSPHATIDYLSERINE DERIVATIVE'
[patent_app_type] => utility
[patent_app_number] => 15/322041
[patent_app_country] => US
[patent_app_date] => 2015-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29145
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15322041
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/322041 | Lysophosphatidylserine derivative | Jul 2, 2015 | Issued |
Array
(
[id] => 11589620
[patent_doc_number] => 20170114031
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-27
[patent_title] => 'Difluoromethyl-nicotinic-indanyl carboxamides'
[patent_app_type] => utility
[patent_app_number] => 15/319161
[patent_app_country] => US
[patent_app_date] => 2015-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13304
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15319161
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/319161 | Herbicidally active N-(1-methyltetrazol-5-yl)benzoic acid amides | Jun 25, 2015 | Issued |
Array
(
[id] => 13065327
[patent_doc_number] => 10053436
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-08-21
[patent_title] => Process for the preparation of substituted oxiranes and triazoles
[patent_app_type] => utility
[patent_app_number] => 15/324312
[patent_app_country] => US
[patent_app_date] => 2015-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 15506
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15324312
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/324312 | Process for the preparation of substituted oxiranes and triazoles | Jun 25, 2015 | Issued |
Array
(
[id] => 11743851
[patent_doc_number] => 20170197924
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-13
[patent_title] => 'Novel 1,2,3 Triazole Antifungal Agents and Preparation Thereof'
[patent_app_type] => utility
[patent_app_number] => 15/320590
[patent_app_country] => US
[patent_app_date] => 2015-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11973
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15320590
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/320590 | 1,2,3 Triazole antifungal agents and preparation thereof | Jun 17, 2015 | Issued |
Array
(
[id] => 11184723
[patent_doc_number] => 09416116
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-08-16
[patent_title] => 'Method of preparation of metaxalone'
[patent_app_type] => utility
[patent_app_number] => 14/742203
[patent_app_country] => US
[patent_app_date] => 2015-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5002
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14742203
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/742203 | Method of preparation of metaxalone | Jun 16, 2015 | Issued |
Array
(
[id] => 10614819
[patent_doc_number] => 09334251
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-10
[patent_title] => 'Compounds for the treatment of neurodegenerative diseases'
[patent_app_type] => utility
[patent_app_number] => 14/740595
[patent_app_country] => US
[patent_app_date] => 2015-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 28921
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14740595
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/740595 | Compounds for the treatment of neurodegenerative diseases | Jun 15, 2015 | Issued |
Array
(
[id] => 11319325
[patent_doc_number] => 09518063
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-12-13
[patent_title] => 'Organic electroluminescent materials and devices'
[patent_app_type] => utility
[patent_app_number] => 14/735589
[patent_app_country] => US
[patent_app_date] => 2015-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12649
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14735589
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/735589 | Organic electroluminescent materials and devices | Jun 9, 2015 | Issued |
Array
(
[id] => 11923875
[patent_doc_number] => 09791450
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-17
[patent_title] => 'Fluorescent compounds'
[patent_app_type] => utility
[patent_app_number] => 14/733764
[patent_app_country] => US
[patent_app_date] => 2015-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 45255
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14733764
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/733764 | Fluorescent compounds | Jun 7, 2015 | Issued |
Array
(
[id] => 12790471
[patent_doc_number] => 20180155326
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-07
[patent_title] => METHOD FOR PREPARING TRITYL CANDESARTAN
[patent_app_type] => utility
[patent_app_number] => 15/578541
[patent_app_country] => US
[patent_app_date] => 2015-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2358
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 169
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15578541
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/578541 | METHOD FOR PREPARING TRITYL CANDESARTAN | Jun 4, 2015 | Abandoned |
Array
(
[id] => 11507234
[patent_doc_number] => 09598380
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-03-21
[patent_title] => 'Facile method for preparation of 5-nitrotetrazolates using a batch system'
[patent_app_type] => utility
[patent_app_number] => 14/731613
[patent_app_country] => US
[patent_app_date] => 2015-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3044
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14731613
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/731613 | Facile method for preparation of 5-nitrotetrazolates using a batch system | Jun 4, 2015 | Issued |
Array
(
[id] => 10457914
[patent_doc_number] => 20150342929
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-03
[patent_title] => 'Mixed ORL1/mu-agonists for the Treatment of Pain'
[patent_app_type] => utility
[patent_app_number] => 14/732451
[patent_app_country] => US
[patent_app_date] => 2015-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 17702
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14732451
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/732451 | Mixed ORL1/mu-agonists for the Treatment of Pain | Jun 4, 2015 | Abandoned |
Array
(
[id] => 11755924
[patent_doc_number] => 20170202791
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-20
[patent_title] => 'N,N-BIS-2-MERCAPTOETHYL ISOPHTHALAMIDE FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES'
[patent_app_type] => utility
[patent_app_number] => 15/313877
[patent_app_country] => US
[patent_app_date] => 2015-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5529
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15313877
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/313877 | N,N-BIS-2-MERCAPTOETHYL ISOPHTHALAMIDE FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | May 28, 2015 | Abandoned |
Array
(
[id] => 11283654
[patent_doc_number] => 09499497
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-22
[patent_title] => 'Compounds useful as inhibitors of indoleamine 2,3-dioxygenase'
[patent_app_type] => utility
[patent_app_number] => 14/722413
[patent_app_country] => US
[patent_app_date] => 2015-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23361
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14722413
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/722413 | Compounds useful as inhibitors of indoleamine 2,3-dioxygenase | May 26, 2015 | Issued |
Array
(
[id] => 16970471
[patent_doc_number] => 11066432
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-20
[patent_title] => Ether phospholipids and method for producing the same
[patent_app_type] => utility
[patent_app_number] => 15/533528
[patent_app_country] => US
[patent_app_date] => 2015-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 7
[patent_no_of_words] => 5762
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15533528
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/533528 | Ether phospholipids and method for producing the same | May 12, 2015 | Issued |
Array
(
[id] => 10362859
[patent_doc_number] => 20150247863
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-03
[patent_title] => 'DERIVATIVES OF 1,2-DIHYDRO-7-HYDROXYQUINOLINES CONTAINING FUSED RINGS'
[patent_app_type] => utility
[patent_app_number] => 14/709886
[patent_app_country] => US
[patent_app_date] => 2015-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 26148
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14709886
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/709886 | DERIVATIVES OF 1,2-DIHYDRO-7-HYDROXYQUINOLINES CONTAINING FUSED RINGS | May 11, 2015 | Abandoned |
Array
(
[id] => 11834553
[patent_doc_number] => 20170216273
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-03
[patent_title] => 'Nicotine Derivatives and Methods of Use'
[patent_app_type] => utility
[patent_app_number] => 15/357071
[patent_app_country] => US
[patent_app_date] => 2015-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8424
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15357071
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/357071 | Nicotine Derivatives and Methods of Use | May 10, 2015 | Abandoned |
Array
(
[id] => 10437010
[patent_doc_number] => 20150322022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-12
[patent_title] => 'THERAPEUTIC CATECHOLS'
[patent_app_type] => utility
[patent_app_number] => 14/709108
[patent_app_country] => US
[patent_app_date] => 2015-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9773
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14709108
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/709108 | Therapeutic catechols | May 10, 2015 | Issued |
Array
(
[id] => 11935086
[patent_doc_number] => 20170239235
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-24
[patent_title] => 'SMALL-MOLECULE UT-A-SELECTIVE UREA TRANSPORT INIHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/310061
[patent_app_country] => US
[patent_app_date] => 2015-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 22829
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15310061
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/310061 | SMALL-MOLECULE UT-A-SELECTIVE UREA TRANSPORT INIHIBITORS | May 7, 2015 | Abandoned |
Array
(
[id] => 11471195
[patent_doc_number] => 20170057978
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-02
[patent_title] => 'ANTI-VIRAL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/308058
[patent_app_country] => US
[patent_app_date] => 2015-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 26399
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15308058
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/308058 | Anti-viral compounds, pharmaceutical compositions, and methods of use thereof | May 7, 2015 | Issued |
Array
(
[id] => 11487013
[patent_doc_number] => 09593078
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-03-14
[patent_title] => 'Crystal forms'
[patent_app_type] => utility
[patent_app_number] => 14/707433
[patent_app_country] => US
[patent_app_date] => 2015-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 19810
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14707433
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/707433 | Crystal forms | May 7, 2015 | Issued |